Dr. Mina Bekheet is a Millennial Serial Entrepreneur and Venture Capitalist. He is the Founder and CEO of Panacea, an innovative enterprise committed to discovering, launching, financing, and scaling the next wave of life sciences and health tech companies while ensuring universal equal access to transformative innovation. Boasting over a decade of experience in pharma, health tech, and biotech, Dr. Bekheet has been instrumental in both launching and investing in numerous ventures. He has built Panacea's extensive portfolio of 400+ start-ups, with a combined value of c. GBP£1.5 billion, and has realised several successful exits. Dr. Bekheet’s work has earned him a spot in Europe’s Forbes’ 30 Under 30 and a role in shaping the UK’s Life Science Strategy through the House of Lords "Bell's Report". He serves on various Boards, advises international organisations, and imparts knowledge as an External Lecturer at Oxford’s Saïd Business School. Dr. Bekheet holds a PhD in Oncology from the University of Oxford and a Masters in Drug Discovery from University College London.
General Inquiries
Forbes Middle East is a licensee of Forbes Media and extends the Forbes brand of journalism across the Arab world. Forbes Middle East’s distinctive editorial style attracts a readership of Arab leaders, entrepreneurs, C-level executives, government officials and investors united by a belief in the spirit of free enterprise and entrepreneurial values.Across the region, Forbes Middle East sets the pace for preemptive business journalism. By uncovering trends and anticipating opportunities in the regional marketplace, each monthly issue brings top executives the information critical to their success – in both Arabic and English language editions. The magazine researches and publishes original rankings, based on methodologies set by Forbes Media.